Hybrigenics announces the implementation of an equity financing line.

Paris, March 22, 2021 – Hybrigenics has prioritized funding proposed by the company IRIS solution that offers very attractive financial conditions, including the absence of commission and complete flexibility with the ability to terminate without charge to print at any time. These funds will allow, like a SPAC1, to seize…
Read More

Bone Therapeutics secures EUR 11 million financing

Gosselies, Belgium, 29 April 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of its key…
Read More